Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPension (IS)Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) Cost of Revenue (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Cost of Revenue for 16 consecutive years, with $5.1 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue fell 86.59% to $5.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $32.2 million through Dec 2025, down 49.03% year-over-year, with the annual reading at $19.2 million for FY2025, 51.19% down from the prior year.
  • Cost of Revenue for Q4 2025 was $5.1 million at Harvard Bioscience, down from $8.6 million in the prior quarter.
  • The five-year high for Cost of Revenue was $38.0 million in Q4 2024, with the low at $5.1 million in Q4 2025.
  • Average Cost of Revenue over 5 years is $12.6 million, with a median of $9.7 million recorded in 2024.
  • The sharpest move saw Cost of Revenue surged 138.56% in 2022, then plummeted 86.59% in 2025.
  • Over 5 years, Cost of Revenue stood at $34.0 million in 2021, then tumbled by 62.91% to $12.6 million in 2022, then skyrocketed by 124.64% to $28.3 million in 2023, then skyrocketed by 34.23% to $38.0 million in 2024, then tumbled by 86.59% to $5.1 million in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $5.1 million, $8.6 million, and $8.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.